LOTRISONE Drug Patent Profile
✉ Email this page to a colleague
When do Lotrisone patents expire, and what generic alternatives are available?
Lotrisone is a drug marketed by Organon and Merck Sharp Dohme and is included in two NDAs.
The generic ingredient in LOTRISONE is betamethasone dipropionate; clotrimazole. There are sixty-six drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the betamethasone dipropionate; clotrimazole profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for LOTRISONE?
- What are the global sales for LOTRISONE?
- What is Average Wholesale Price for LOTRISONE?
Summary for LOTRISONE
US Patents: | 0 |
Applicants: | 2 |
NDAs: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 72 |
Clinical Trials: | 1 |
Drug Prices: | Drug price information for LOTRISONE |
What excipients (inactive ingredients) are in LOTRISONE? | LOTRISONE excipients list |
DailyMed Link: | LOTRISONE at DailyMed |
Recent Clinical Trials for LOTRISONE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Jilin University | Phase 2 |
US Patents and Regulatory Information for LOTRISONE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Organon | LOTRISONE | betamethasone dipropionate; clotrimazole | CREAM;TOPICAL | 018827-001 | Jul 10, 1984 | DISCN | Yes | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
Merck Sharp Dohme | LOTRISONE | betamethasone dipropionate; clotrimazole | LOTION;TOPICAL | 020010-001 | Dec 8, 2000 | DISCN | Yes | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for LOTRISONE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Organon | LOTRISONE | betamethasone dipropionate; clotrimazole | CREAM;TOPICAL | 018827-001 | Jul 10, 1984 | ⤷ Subscribe | ⤷ Subscribe |
Organon | LOTRISONE | betamethasone dipropionate; clotrimazole | CREAM;TOPICAL | 018827-001 | Jul 10, 1984 | ⤷ Subscribe | ⤷ Subscribe |
Organon | LOTRISONE | betamethasone dipropionate; clotrimazole | CREAM;TOPICAL | 018827-001 | Jul 10, 1984 | ⤷ Subscribe | ⤷ Subscribe |
Organon | LOTRISONE | betamethasone dipropionate; clotrimazole | CREAM;TOPICAL | 018827-001 | Jul 10, 1984 | ⤷ Subscribe | ⤷ Subscribe |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for LOTRISONE
See the table below for patents covering LOTRISONE around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Mexico | 9203283 | COMBINACION DE CLOTRIMAZOL-DIPROPIONATO DE BETAMETASONA. | ⤷ Subscribe |
Germany | 1670932 | ⤷ Subscribe | |
Belgium | 721378 | ⤷ Subscribe | |
Austria | 7457 | ⤷ Subscribe | |
Spain | 358154 | ⤷ Subscribe | |
Norway | 124110 | ⤷ Subscribe | |
>Country | >Patent Number | >Title | >Estimated Expiration |
LOTRISONE Market Analysis and Financial Projection Experimental
More… ↓